Lithotritie vésiculaire par ondes de choc extracorporelles: importance des critères de sélection [Extracorporeal shockwave lithotripsy of the gallbladder: importance of selection criteria].

Détails

ID Serval
serval:BIB_51E995607348
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Lithotritie vésiculaire par ondes de choc extracorporelles: importance des critères de sélection [Extracorporeal shockwave lithotripsy of the gallbladder: importance of selection criteria].
Périodique
Schweizerische Medizinische Wochenschrift
Auteur⸱e⸱s
Thorens J., Schnegg J.F., Fasel J., Deslarzes C., Duvoisin B., Schnyder P., Gonvers J.J., Blum A.L.
ISSN
0036-7672 (Print)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
1993
Peer-reviewed
Oui
Volume
123
Numéro
14
Pages
642-648
Langue
français
Notes
Publication types: Comparative Study ; English Abstract ; Journal Article
Publication Status: ppublish
Résumé
In recent years, a number of alternatives to surgery for gallstones have been developed. Among them, extracorporeal shock-wave lithotripsy (ESWL) was promising, being non-invasive and risk-free. Nevertheless, its results vary according to the size, number and composition of the stones and according to the bile acids treatment used for fragment dissolution. To better evaluate the importance of these factors, we have widened the selection criteria currently used (1 to 3 non-calcified stones with a diameter below 30 mm) by including patients with large stones (up to 40 mm in diameter), multiple stones (up to 10 stones) and calcified stones. We also compared, for efficacy of fragment dissolution after ESWL, treatment by ursodeoxycholic acid alone as opposed to a mixture with chenodeoxycholic acid. Our results were (1) significant lessening of the fragmentation rate and of the number of gallbladders free of stones 1 year after ESWL when selection criteria are widened; (2) a mixture of ursodeoxycholic and chenodeoxycholic acids may favour fragment dissolution after ESWL compared to treatment by ursodeoxycholic acid alone.
Mots-clé
Adolescent, Adult, Aged, Aged, 80 and over, Chenodeoxycholic Acid/administration & dosage, Cholelithiasis/drug therapy, Cholelithiasis/therapy, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Lithotripsy/adverse effects, Lithotripsy/contraindications, Male, Middle Aged, Prognosis, Ursodeoxycholic Acid/administration & dosage
Pubmed
Web of science
Création de la notice
11/04/2008 12:40
Dernière modification de la notice
20/08/2019 15:07
Données d'usage